Securing retatrutide in the United States currently presents a challenge as it's not yet authorized for widespread public dispensing. Doctors participating in clinical trials may be dispensing it, but access is limited to those participating . Specialized dispensaries, operating under specific regulations, *might* offer compounded versions, but qua